Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species–Mediated Mitochondrial Dysfunction

Abstract

BackgroundPulmonary arterial remodeling, a main characteristic of hypoxic pulmonary hypertension, can gradually reverse once oxygen has been restored. Previous studies documented that apoptosis increased markedly during the reversal of remodeled pulmonary arteries, but the types of cells and mechanisms related to the apoptosis have remained elusive. This study aimed to determine whether pulmonary artery smooth muscle cell (PASMC)‐specific apoptosis was involved in the reoxygenation‐induced reversal of hypoxic pulmonary arterial remodeling and elucidate the underlying mechanism.Methods and ResultsHypoxic pulmonary hypertension was induced in adult male Sprague‐Dawley rats (n=6/group) by chronic hypobaric hypoxia. and the hypoxic pulmonary hypertension rats were then transferred to a normoxia condition. During reoxygenation, hypoxia‐induced pulmonary arterial remodeling gradually reversed. The reversal of remodeled pulmonary arteries was associated with increased H2O2 and with changes in lung expression of cleaved caspase3/PARP, Bax, and Bcl‐2, consistent with increased apoptosis. The PASMC apoptosis, in particular, increased remarkably during this reversal. In vitro, reoxygenation induced the apoptosis of cultured rat primary PASMCs accompanied by increased mitochondrial reactive oxygen species, mitochondrial dysfunction, and the release of cytochrome C from mitochondria to cytoplasm. Clearance of reactive oxygen species alleviated mitochondrial dysfunction as well as the release of cytochrome C and, finally, decreased PASMC apoptosis.ConclusionsReoxygenation‐induced apoptosis of PASMCs is implicated in the reversal of hypoxic pulmonary arterial remodeling, which may be attributed to the mitochondrial reactive oxygen species–mediated mitochondrial dysfunction.

Metformin Promotes the Survival of Random-Pattern Skin Flaps by Inducing Autophagy via the AMPK-mTOR-TFEB signaling pathway

“…Ischemia-reperfusion injury-induced apoptosis ordinarily accompanies high levels of ROS production 45. Excessive ROS levels can increase the permeability of the inner mitochondrial membrane and disturb the balance of Bcl-2-like anti-apoptotic factors and Bax-like pro-apoptotic factors, resulting in the release of pro-apoptotic proteins, such as CYC, into the intermembrane space 46. Release of CYC activates CASP3, which can induce apoptosis 47.…”

NR4A1 contributes to high-fat associated endothelial dysfunction by promoting CaMKII-Parkin-mitophagy pathways

“…Mitochondria, which are organelles that are present in all cells of the human body except erythrocytes, play a pivotal role in energy production (Caja and Enriquez 2017;Vendrov et al 2017). In addition to this vital function, mitochondria are involved in other complex processes, such as cellular energy metabolism, oxidative stress regulation, calcium signaling modification, cellular proliferation, and cellular death (especially mitochondria-dependent caspase 9 apoptosis) (Chen et al 2017;Wang et al 2017a;Zhou et al 2014Zhou et al , 2015a. Notably, previous studies have indicated that endothelial viability under high-fat stimulation is related to mitochondrial apoptosis (Chattopadhyay et al 2017;Zhang et al 2016;Zhou et al 2017a).…”

Dl-3-n-butylphthalide inhibits phenytoin-induced neuronal apoptosis in rat hippocampus and cerebellum

“…Some studies have shown that PHT causes neuronal apoptosis (Bittigau et al, 2002;Zhao et al, 2003). Apoptosis refers to a form of cell death controlled by genes, regulates the development of the body and maintains the stability of the internal environment (Abeti et al, 2016;Chen et al, 2017;Gahl et al, 2016;Han et al, 2018). Studies have shown that neuronal apoptosis is a key event in the pathogenesis of epilepsy, cerebral ischemia and other diseases (Abiega et al, 2016;Dai et al, 2018;Li et al, 2017;Singh et al, 2019).…”